4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000046
CEO bought 55,000 shares at an average $0.01 ($597)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-08-16 | Purchase : show line 1 in the form | +5,000 | $0.01 | $55 | 25,015,297 | D |
| 2019-08-16 | Purchase : show line 2 in the form | +5,000 | $0.01 | $55 | 25,020,297 | D |
| 2019-08-16 | Purchase : show line 3 in the form | +20,000 | $0.01 | $218 | 25,040,297 | D |
| 2019-08-16 | Purchase : show line 4 in the form | +10,000 | $0.01 | $109 | 25,050,297 | D |
| 2019-08-16 | Purchase : show line 5 in the form | +5,000 | $0.01 | $55 | 25,055,297 | D |
| 2019-08-16 | Purchase : show line 6 in the form | +5,000 | $0.01 | $54 | 25,060,297 | D |
| 2019-08-19 | Purchase : show line 7 in the form | +5,000 | $0.01 | $53 | 25,065,297 | D |
| Open-market purchases · 55,000 sh · avg $0.01 · $597 | ||||||
Loading xslF345X03/primary_doc.xml…